Brainstorm Cell Therapeutics (BCLI) Tops Q2 EPS by 1c

Go back to Brainstorm Cell Therapeutics (BCLI) Tops Q2 EPS by 1c
Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) Delayed: 1.17 --0 (-0%)
Previous Close $1.17    52 Week High $3.87 
Open $1.17    52 Week Low $1.90 
Day High $1.17    P/E N/A 
Day Low $1.17    EPS $-0.03 
Volume